Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Martha GrodzkiI Zehbe

Abstract

To test the significance of human papillomavirus (HPV) type 16 and HPV16 E6 variants as risk factors for viral persistence and progression to high-grade lesion, we did a nested case-control study within a cohort study of >15,000 Caucasian French women. Three groups infected with high-risk HPV were compared: (a) women with cleared infection (controls, n = 201), (b) women with persistent infection (cases, n = 87), and (c) women who progressed into high-grade lesion (cases, n = 58). Women with persistent HPV infection and those that progressed into high-grade lesions were likelier to harbor HPV16 than other high-risk HPV types [odds ratio (OR), 2.4; 95% confidence interval (95% CI), 1.3-4.3 and OR, 4.2; 95% CI, 2.2-8.1, respectively]. Notably, especially elevated ORs of persistence (3.0; 95% CI, 1.4-6.7) and progression (6.2; 95% CI, 2.7-14.3) were found among women who harbored the HPV16 350G variant. Thus, HPV type and HPV16 variant seem to be risk factors for viral persistence and progression of infections into high-grade cervical lesions.

References

Aug 1, 1985·Virology·K SeedorfW G Röwekamp
Sep 6, 2001·Journal of the National Cancer Institute·J BerumenA Madrigal-de la Campa
Mar 22, 2002·The Lancet Oncology·Alex Ferenczy, Eduardo Franco
May 10, 2002·The Journal of Infectious Diseases·Maria M Da CostaJoel M Palefsky
Jun 5, 2002·Nature Reviews. Cancer·Harald zur Hausen
Aug 27, 2002·The Journal of Infectious Diseases·Paul K S ChanAugustine F Cheng
Dec 7, 2002·Gynecologic Oncology·M Radhakrishna PillaiBrian Herman
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Feb 26, 2003·Journal of Medical Virology·María Alejandra PicconiAngélica Teyssié
Jan 30, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·María del Refugio González-LosaAlejandro García-Carrancá
Apr 24, 2004·The Journal of General Virology·Anil K ChaturvediMichael E Hagensee
Jan 27, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S KangH P Lee
Mar 9, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Janet G Baseman, Laura A Koutsky
May 26, 2005·Virology·Mark SchiffmanRobert D Burk
Jun 9, 2005·Cancer Letters·Narayanan SathishGeorge Chandy
Dec 7, 2005·International Journal of Cancer. Journal International Du Cancer·Hans-Ulrich BernardS Terence Dunn

❮ Previous
Next ❯

Citations

Sep 11, 2013·Revue D'épidémiologie Et De Santé Publique·O GanryJ-L Schmit
Sep 28, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Gabriella Lillsunde LarssonMats G Karlsson
Apr 12, 2012·Journal of Virology·Iris CornetUNKNOWN IARC HPV Variant Study Group
Jun 28, 2011·Molecular Cancer·Ingeborg ZehbeLevana Sherman
Dec 29, 2006·Infectious Agents and Cancer·Annarosa Del MistroDaria Minucci
Jan 25, 2013·Infectious Agents and Cancer·Iris CornetChristine Clavel
Apr 21, 2009·Future Oncology·Patrícia Savio de Araujo SouzaPaulo Cesar Maciag
Dec 4, 2012·International Journal of Molecular Sciences·Zhengrong SunQiang Ruan
Jan 6, 2012·World Journal of Gastroenterology : WJG·Andres CastilloSuminori Akiba
Feb 14, 2013·Gynecologic Oncology·Gabriella Lillsunde LarssonMats G Karlsson
Oct 25, 2013·Journal of Medical Virology·Polona J MaverMario Poljak
Apr 10, 2009·International Journal of Cancer. Journal International Du Cancer·M R PillaiN Singh
Jan 22, 2008·Journal of Medical Virology·Thomas HillerThomas Iftner
Sep 15, 2007·Journal of Medical Virology·Yulia AsadurianLevana Sherman
Sep 4, 2007·International Journal of Cancer. Journal International Du Cancer·Maria Lina TorneselloFranco M Buonaguro
Jul 16, 2013·Journal of Medical Virology·Ya-Ju ChangUNKNOWN CBCSP-HPV Study Group
Feb 1, 2012·NMR in Biomedicine·Markus WeigerVolker Rasche
Sep 28, 2012·International Journal of Cancer. Journal International Du Cancer·Aurélie FormentinFrancois Coutlée
Dec 1, 2010·The Journal of Obstetrics and Gynaecology Research·Eda Vrtačnik BokalNina Jančar
Jul 2, 2009·International Journal of Cancer. Journal International Du Cancer·Rosemary E ZunaTravis Teel
Mar 13, 2014·Journal of Medical Virology·Priyanka S GokhaleJayanti Mania-Pramanik
May 12, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Montserrat TorresMassimo Tommasino
Oct 8, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Peechanika ChopjittNicha Charoensri
Mar 23, 2011·Journal of Virological Methods·S PerezS Melon
Aug 20, 2016·Infectious Agents and Cancer·Hongchang HeRenfu Shao
Oct 30, 2016·Cancer Medicine·Sara Nicolás-PárragaUNKNOWN RIS HPV TT and HPV VVAP study groups

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.